Core Viewpoint - Smoore International (06969) has seen a significant decline in stock price, dropping over 30% from its year-to-date high, with a current trading price of 16.08 HKD [1] Company Summary - Smoore International's stock fell over 7%, reaching a low of 15.85 HKD during trading, with a trading volume of 261 million HKD [1] - UBS reported a meeting with Japan Tobacco's management and an investor meeting with Smoore's management in Shenzhen [1] Industry Summary - The U.S. has intensified its crackdown on illegal e-cigarettes since early 2025, but inconsistent enforcement may weaken its impact, as indicated by a 39% increase in e-cigarette exports from China in August [1] - UBS forecasts a 20% year-on-year revenue growth for Smoore International in 2025, driven primarily by e-cigarette sales, but anticipates a 40% decline in net profit due to rising R&D and sales expenses, along with margin pressure [1] - UBS's net profit projections for Smoore International from 2025 to 2027 are 18-45% lower than market consensus, maintaining a "Sell" rating with a target price of 13.11 HKD [1]

Core Viewpoint - UBS maintains a "Sell" rating on Smoore International (06969) with a target price of HKD 13.11, citing concerns over profitability despite expected revenue growth driven by e-cigarette sales [1] Group 1: Company Insights - UBS recently met with management from Japan Tobacco in Tokyo and held an investor meeting with Smoore's management in Shenzhen [1] - The firm anticipates a 20% year-on-year revenue growth in 2025, primarily driven by e-cigarette sales [1] - However, net profit is expected to decline by 40% year-on-year due to rising R&D and sales expenses, along with pressure on gross margins [1] Group 2: Market and Regulatory Environment - The impact of U.S. enforcement against illegal e-cigarettes may weaken due to inconsistent enforcement, as indicated by on-the-ground feedback [1] - Chinese customs data shows a 39% increase in e-cigarette exports in August, suggesting that Chinese e-cigarette exporters are adapting to U.S. enforcement measures [1] - UBS's net profit forecasts for 2025-2027 are 18-45% lower than market consensus [1]

Core Viewpoint - UBS maintains a "Sell" rating on Smoore International (06969) with a target price of HKD 13.11, citing concerns over rising costs and declining net profits despite expected revenue growth driven by e-cigarette sales [1] Group 1: Company Insights - UBS recently met with management from Japan Tobacco in Tokyo and held an investor meeting with Smoore's management in Shenzhen [1] - The firm notes that while the U.S. has intensified efforts against illegal e-cigarettes since early 2025, inconsistent enforcement may lessen the impact of these measures [1] - Chinese customs data indicates a 39% increase in e-cigarette exports in August, suggesting that Chinese e-cigarette exporters are adapting to U.S. enforcement [1] Group 2: Financial Projections - UBS forecasts a 20% year-on-year revenue growth in 2025, primarily driven by e-cigarette sales [1] - However, net profit is expected to decline by 40% year-on-year due to rising R&D and sales expenses, along with pressure on gross margins [1] - The firm's net profit projections for 2025-2027 are 18-45% lower than market consensus [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 思摩爾國際控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 FF301 截至月份: 2025年9月30日 狀態: 新提交 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06969 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | USD | | 0.01 USD | | 100,000,000 | | 增加 / 減少 (-) | | | 0 | | USD | | 0 | | 本月底結存 | | 10,000,000,000 | USD | | 0.01 USD | | 100,000,000 | 本月底法定/註冊股本總額： ...

Core Viewpoint - EVE Energy announced that its indirect associate, Smoore International Holdings Limited, will declare an interim dividend of HKD 0.20 per share, totaling approximately HKD 1,238,220,000, with EVE's subsidiary receiving HKD 374,833,000 in cash dividends [1] Group 1 - Smoore International will release its interim performance announcement for the six months ending June 30, 2025, on August 20, 2025 [1] - The interim dividend will be paid to shareholders listed on the register as of September 11, 2025 [1] - EVE's wholly-owned subsidiary, EVEBATTERYINVESTMENTLTD., has received a cash dividend amounting to HKD 374,833,000 [1]

亿纬锂能9月30日公告，孙公司EBIL收到参股公司思摩尔国际现金分红3.75亿港币。 ...

Core Insights - The report from CICC indicates that the 2025 National Day and Mid-Autumn Festival holiday will span 8 days, coupled with more flexible leave arrangements, which is expected to stimulate a more active consumption window [1] - The Ministry of Culture and Tourism has announced that over 480 million yuan in consumption subsidies will be distributed during the consumption month, which is anticipated to further enhance residents' willingness to spend and boost holiday consumption [1] Group 1: Consumer Trends - The extended holiday peak is expected to improve travel sentiment year-on-year [1] - The report emphasizes a long-term focus on self-consumption, recommending sectors such as trendy toys and e-cigarettes, with specific companies like Pop Mart, Blokus, and Smoore International highlighted [1] Group 2: Domestic Brands and Policy Impact - The report suggests a trend towards the rise of domestic brands, recommending beauty and personal care sectors, including companies like Mao Geping, Juzhibio, Shanghai Jahwa, and Shanghai Jahwa [1] - Attention is drawn to sectors benefiting from policy catalysts, particularly retail, supported by domestic demand policies and seasonal boosts [1]

Group 1: Company Developments - Transpire Bio, a wholly-owned subsidiary of Smoore International, has submitted an Abbreviated New Drug Application (ANDA) for Breo® Ellipta® and received acceptance from the FDA on September 23 [1][1] - If approved, Transpire Bio will have a 180-day exclusivity period in the U.S. market for Breo® Ellipta®, which is used for the maintenance treatment of asthma and COPD, with projected sales of $2.02 billion in 2024 [1][1] - This breakthrough highlights Transpire Bio's strategic positioning in the complex generic drug sector and strengthens Smoore International's innovative advantage in the global inhalation drug market [1][1] Group 2: Industry Trends - The FDA has launched a pilot program to enhance the efficiency of pre-market tobacco product applications (PMTAs) for nicotine pouch products, aiming for more frequent feedback and shorter review times [2][2] - The pilot program reflects the FDA's commitment to improving regulatory efficiency while maintaining scientific standards for tobacco product reviews [2][2] - As of now, the FDA has authorized 20 nicotine pouch products, with potential for more varieties in the future [2][2] Group 3: Export Data - In the first eight months of 2025, the export value of e-cigarettes and similar personal vaporizing devices reached $2.116 billion, a year-on-year increase of 14.55%, while other non-combustible nicotine products saw a decrease of 18.31% [3][3] - In August 2025, the export value of e-cigarettes was $301 million, up 34.01% year-on-year, while other nicotine products reached $635 million, down 5.68% year-on-year [3][3] - The average export price for e-cigarettes was $4.46 per unit, with an overall export price of $45.07 per kilogram in August [3][3] Group 4: Regional Insights - The top five export destinations (U.S., U.K., Germany, South Korea, UAE) accounted for 62.32% of total exports in the first eight months of 2025, a slight decrease of 0.56 percentage points year-on-year [4][4] - The U.S. remains the largest market with an export value of $2.199 billion, down 8.67% year-on-year, representing 33.56% of total exports [4][4] - Notable growth was observed in exports to the UAE and Indonesia, with increases of 60.57% and 67.25% respectively, while South Korea, Russia, and the Netherlands experienced significant declines [4][4]

Core Viewpoint - Smoore International (06969) experienced a significant intraday increase of over 5%, closing at HKD 18.07 with a trading volume of HKD 144 million, driven by the launch of the Glo Hilo product in Poland and anticipated market expansions [1] Group 1: Product Launch and Market Expansion - On September 18, the Glo Hilo product was officially launched on the Glo website in Poland, featuring improved separate and integrated devices with seven color options and an initial offering of 13 different flavored tobacco products (8 tea-based and 5 tobacco flavors) [1] - The marketing strategy includes a promotional campaign by British American Tobacco, offering four packs of tobacco with the purchase of heating devices, indicating a strong push for the Glo Hilo product [1] - The next anticipated market for Glo Hilo is Italy, projected to be the third-largest global market for heated non-combustible (HNB) products by 2024, with expectations for orderly expansion into other incremental markets [1] Group 2: Market Expectations and Valuation - According to CICC, as the product matures, HNB new products are generally expanding globally by reusing trial sales experiences, which is expected to adjust market expectations regarding market entry pace and user growth rates [1] - The improvement in market share, revenue growth, and profit realization are expected to anchor reasonable valuations for leading international tobacco brands, which are leveraging innovative new products to enhance their market share [1]

Core Viewpoint - Smoore International (06969) experienced a significant stock price increase of 5.67%, reaching HKD 18.07, with a trading volume of HKD 144 million, following the launch of the Glo Hilo product in Poland [1] Group 1: Product Launch and Market Expansion - On September 18, Glo officially launched the Glo Hilo product in Poland, featuring improved separate and integrated devices with seven color options and an expanded selection of 13 flavors (8 tea-based and 5 tobacco flavors) [1] - British American Tobacco is enhancing the marketing efforts for Glo Hilo by offering promotional activities, such as providing four packs of cigarettes with the purchase of heating devices [1] - The next anticipated market for Glo Hilo is Italy, projected to be the third-largest global market for heated non-combustible (HNB) products in 2024, with expectations for orderly expansion into other incremental markets [1] Group 2: Market Expectations and Valuation - CICC noted that as the product matures, HNB new products are generally expanding globally by reusing trial sales experiences, which is expected to adjust market expectations based on new market development pace and user growth rates [1] - The improvement in market share, revenue growth, and profit realization are expected to anchor reasonable valuations for leading international tobacco brands leveraging innovative new products [1]